Dow Up0.41% Nasdaq Up1.23%

Merck & Co. Inc. (MRK)

-NYSE

48.74 Up 1.13(2.38%) 4:00PM EDT|After Hours : 48.74 0.00 (0.00%) 5:18PM EDT

Add to Portfolio
ProfileGet Profile for:
Merck & Co. Inc.
One Merck Drive
Whitehouse Station, NJ 08889-0100
United States - Map
Phone: 908-423-1000
Fax: 908-735-1253
Website: http://www.merck.com

Details 
Index Membership:Dow Jones Composite
Dow Industrials
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:83,000

Business Summary 

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Merck & Co. Inc.

Corporate Governance 
Merck & Co. Inc.’s ISS Governance QuickScore as of Sep 1, 2013 is 1. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 2; Compensation: 1.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Kenneth C. Frazier , 58
Chairman, Chief Exec. Officer and Pres
4.06M0.00
Mr. Peter N. Kellogg BSE,MBA, 56
Chief Financial Officer and Exec. VP
2.05M0.00
Mr. Bruce N. Kuhlik , 56
Exec. VP and Gen. Counsel
1.71M921.00K
Mr. Adam H. Schechter , 48
Exec. VP and Pres of Global Human Health
2.24M1.51M
Mr. John Canan , 57
Principal Accounting Officer, Sr. VP of Fin. and Global Controller
N/AN/A
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders